Page 359 - 20dynamics of cancer
P. 359

344                                                REFERENCES

                                progeny in human epidermis. Journal of Investigative Dermatology 124:367–
                                372.
                              Giebel, B., Zhang, T., Beckmann, J., Spanholtz, J., Wernet, P., Ho, A. D., and Pun-
                                zel, M. 2006. Primitive human hematopoietic cells give rise to differentially
                                specified daughter cells upon their initial cell division. Blood 107:2146–2152.
                              Gottlieb, B., Beitel, L. K., and Trifiro, M. A. 2001. Somatic mosaicism and variable
                                expressivity. Trends in Genetics 17:79–82.
                              Greenhalgh, D. A., Wang, X. J., Donehower, L. A., and Roop, D. R. 1996. Para-
                                doxical tumor inhibitory effect of p53 loss in transgenic mice expressing
                                epidermal-targeted v-rasHa, v-fos, or human transforming growth factor al-
                                pha. Cancer Research 56:4413–4423.
                              Greenlee, R. T., Murray, T., Bolden, S., and Wingo, P. A. 2000. Cancer statistics,
                                2000. CA: A Cancer Journal for Clinicians 50:7–33.
                              Grossman, L., Matanoski, G., Farmer, E., Hedayati, M., Ray, S., Trock, B., Hanfelt,
                                J., Roush, G., Berwick, M., and Hu, J. J. 1999. DNA repair as a susceptibility
                                factor in chronic diseases in human populations. In Dizdaroglu, M., and
                                Karakaya, A. E., eds., Advances in DNA Damage and Repair, pp. 149–167.
                                Kluwer Academic/Plenum Publishers, New York.
                              Gu, J., Zhao, H., Dinney, C. P., Zhu, Y., Leibovici, D., Bermejo, C. E., Grossman,
                                H. B., and Wu, X. 2005. Nucleotide excision repair gene polymorphisms and
                                recurrence after treatment for superficial bladder cancer. Clinical Cancer
                                Research 11:1408–1415.
                              Guerrette, S., Acharya, S., and Fishel, R. 1999. The interaction of the human MutL
                                homologues in hereditary nonpolyposis colon cancer. Journal of Biological
                                Chemistry 274:6336–6341.
                              Guerrette, S., Wilson, T., Gradia, S., and Fishel, R. 1998. Interactions of hu-
                                man hMSH2 with hMSH3 and hMSH2 with hMSH6: examination of mutations
                                found in hereditary nonpolyposis colorectal cancer. Molecular and Cellular
                                Biology 18:6616–6623.
                              Gutmann, D. H., and Collins, F. S. 2002. Neurofibromatosis I. In Vogelstein, B.,
                                and Kinzler, K. W., eds., The Genetic Basis of Human Cancer (2nd edition).,
                                pp. 417–437. McGraw-Hill, New York.
                              Haenszel, W., and Kurihara, M. 1968. Studies of Japanese migrants. I. Mortality
                                from cancer and other diseases among Japanese in the United States. Journal
                                of the National Cancer Institute 40:43–68.
                              Hall, B. G. 2004. Phylogenetic Trees Made Easy: A How-To Manual (2nd edition).
                                Sinauer Associates, Sunderland, MA.
                              Halpern, M. T., Gillespie, B. W., and Warner, K. E. 1993. Patterns of absolute risk
                                of lung cancer mortality in former smokers. Journal of the National Cancer
                                Institute 85:457–464.
                              Han, J., Colditz, G. A., Samson, L. D., and Hunter, D. J. 2004. Polymorphisms in
                                DNA double-strand break repair genes and skin cancer risk. Cancer Research
                                64:3009–3013.
   354   355   356   357   358   359   360   361   362   363   364